Those with Type 2 Diabetes Have a 50% Greater Risk of Dementia
Conclusion
In diabetic patients those initiating metformin had a five year reduced risk of dementia in comparison to patients initiating other therapies.
Animal models suggest metformin may contribute to neurogenesis and trials are evaluating metformin as a potential therapeutic for mild cognitive impairment. These results are preliminary evidence that benefits of insulin sensitizers may extend beyond glycemic control to neurocognitive health.
Related Content
What is the Difference Between Alzheimer’s and Dementia
Test Your Memory for Alzheimer's (5 Best Tests)
How to Reduce Memory Loss
Is Alzheimer's World an Irrational Place?
Communicating in Alzheimer's World
The Seven Stages of Alzheimer's
To learn more about Alzheimer's and Dementia visit the Alzheimer's Reading Room.
Source: Alzheimer's Reading Room, The - Category: Dementia Authors: Bob DeMarco Source Type: blogs
More News: Alzheimer's | Amnesia | Brain | Clinical Trials | Dementia | Diabetes | Diabetes Type 2 | Education | Endocrinology | Fortamet | Health | Insulin | Learning | Metformin | Neurology | Primary Care | Study | Universities & Medical Training